Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Return on Capital Employed Overview: SolarEdge Technologies

After pulling data from Benzinga Pro it seems like during Q2, SolarEdge Technologies (NASDAQ:SEDG) earned $55.56 million, a 25.9% increase from the preceding quarter.

After pulling data from Benzinga Pro it seems like during Q2, SolarEdge Technologies (NASDAQ:SEDG) earned $55.56 million, a 25.9% increase from the preceding quarter. SolarEdge Technologies also posted a total of $480.06 million in sales, a 18.39% increase since Q1. SolarEdge Technologies earned $44.13 million, and sales totaled $405.49 million in Q1.

What Is ROCE?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company’s ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q2, SolarEdge Technologies posted an ROCE of 0.05%.

Keep in mind, while ROCE is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.

In SolarEdge Technologies’s case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions.

Analyst Predictions

SolarEdge Technologies reported Q2 earnings per share at $1.28/share, which beat analyst predictions of $1.12/share.

Total
0
Shares
Related Posts
Read More

Preview: Edwards Lifesciences’s Earnings

Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Edwards Lifesciences will likely report an Earnings Per Share (EPS) of $0.55.

EW